Company Score

Industry Pharmaceuticals, Biotechnology & Life Sciences
Country Switzerland
Year Added 2018
Impact Ratings 600
Impact Notes 22
SDG Covered 5 out of 17

Novartis International AG is a Swiss multinational pharmaceutical company. It is one of the largest pharmaceutical companies in the world and specialises in research, development and manufacturing of pharmaceuticals.

Novartis’ areas of business include pharmaceuticals, generic drugs, over-the-counter drugs, vaccines, diagnostics, contact lenses and animal health. It manufactures the drugs Clozaril, Voltaren, Tegretol, Diovan, Gleevec/Glivec, Neoral/Sandimmun, Femara, Ritalin, Lamisil, and many more.

Read about Novartis and its impact below.

Impact notes

Good Health and Well-being

Novartis provided health education to 10 million people in 2019 through Novartis Social Business program

Profile Shubham Bakolia
Icon time Fri Jul 3rd, 2020 at 6:14am

According to the WHO, over four million people lack access to quality health care and medical education globally1. This is mainly because of the uneven availability of health workers and accessibility to medical educational programs around the world1.

Climate Action

Novartis reduces 80,000 tons of Scope 1 & 2 CO2 emissions in 2019

Profile Shubham Bakolia
Icon time Thu Jul 2nd, 2020 at 7:56am

In 2018, 6,667 million metric tons of CO2 (81% in GHGs) emissions were recorded 1. 48.6 tonnes of CO2 equivalent per million dollars emission came from the pharmaceutical industry in 2015 globally 2 which was 55% more than the automotive sector for the same year 2.

Gender Equality

44% of Novartis’s managerial positions were represented by women in 2019, an increase from 41% in 2017

Profile Sunny Dutt Sharma
Icon time Mon Jun 29th, 2020 at 7:24am

The pharmaceutical industry worldwide struggles to make progress with gender balance. According to a Credit Suisse report, the ratio of women in senior management roles decreased to 15.5% in 2016 as compared to 18.9% in 2014 1. As per a report by VERCIDA Group, only 28 out of 122 positions on the executive committee were held by women in the top 10 pharmaceutical companies globally in 2018 2.

Gender Equality

82% of Novartis employees across more than 40 countries covered under equal pay parental policy

Profile Sandhyani.Borah
Icon time Tue May 19th, 2020 at 8:54am

According to the US department of labor, 70% of men take ten or fewer days of parental leaves on an average1, p2. 48% of men working full time reported they could not fulfill family responsibilities due to job demands 1, p3. According to a survey conducted by SHRM, only 15% of men receive some replacement pay during paternity leaves as compared to 58% of women 2, p26.

Gender Equality

Novartis fostering equal share of females in leadership roles with its Executive Female Leadership Program

Profile Ekta Srivastava
Icon time Mon Apr 27th, 2020 at 10:12am

A Korn Ferry research across 90 countries found that women outperform men in 11 of 12 key emotional intelligence competencies correlated with leadership10. In reality, however, the lack of female representation in both public and private-sector leadership positions is an issue of concern all over the world. As of 2018, women are just 5% of Fortune 500 CEOs, down from a record high of 6% in 20171. Just 5.1% of chief executives and 11.5% of other top executives of S&P 1500 companies were women in 2016-172